Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction

Seminars in Reproductive Medicine

Volumn 24, Issue 3, 2006, Pages 168-177

  Heindel, Jerrold J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Development; Environmental exposures; Epigenetics; Reproduction; Transgenerational effects

Indexed keywords

ENVIRONMENTAL CHEMICAL;

ARTICLE; DEVELOPMENT; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION REGULATION; GENITAL SYSTEM DISEASE; HUMAN; NONHUMAN; PRENATAL EXPOSURE; REPRODUCTIVE TOXICITY;

ANIMALS; DIETHYLSTILBESTROL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMAN DEVELOPMENT; HUMANS; INFERTILITY; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSTATE; REPRODUCTION;

EID: 33745728737     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-944423     Document Type: Article

References (65)

1. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 2004;56:311-317
2. Bern H. The fragile fetus. In: Colborn T, Clement C, eds. Chemically-Induced Alternations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific; 1992
3. Miller KP, Gorgeest C, Greenfeld C, Tomic D, Flaws JA. In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharmacol 2004;198:111-131
4. Vidaeff AC, Sever LE. In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiologic evidence. Reprod Toxicol 2005; 20:5-20
5. Lau C, Rogers JM. Embryonic and fetal programming of physiological disorders in adulthood. Birth Defects Res C Embryo Today 2004;72:300-302
6. Drake AJ, Walker BR. The intergenerational effects of fetal programming: non genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol 2005;180:1-16
7. Needham LL, Sexton K. Assessing children's exposure to hazardous environmental chemicals: an overview of selected research challenges and complexities. J Expo Anal Environ Epidemiol 2000;10:611-629
8. Mori C, Komiyama M, Adachi T, et al. Application of toxicogenomic analysis to risk assessment of delayed long-term effects of multiple chemicals, including endocrine disruptors in human fetuses. Environ Health Perspect Toxicogenomics 2003;111:7-13
9. Younglai EV, Foster WG, Hughes EG, Trim K, Farrell JF. Levels of environmental contaminants in human follicular fluid, serum and seminal plasma of couples undergoing in vitro fertilization. Arch Environ Contam Toxicol 2002;43:121-126
10. Environmental Working Group. Body burden: the pollution in newborns. Available at: http://www.ewg.org/reports/bodyburden2. Accessed September 15, 2005
11. CDC. National Report on Human Exposures to Environmental Chemicals, http://www.cdc.gov/exposurereport. Accessed September 15, 2005
12. Herbst AL, Ulfeder H, Poskanzer DC, Longo LD. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-881
13. Palmer JR, Hatch EE, Rosenberg CL, et al. Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 2002;13:753-758
14. McLachlan JA, Newbold RR, Bullock BC. Long term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 1980;40:3988-3999
15. Newbold RR, Bullock BC, McLachlan JA. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 1990;50:7677-7681
16. Li S, Hansman R, Newbold R, Davis B, McLachlan J. Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation of its exon-4 in mouse uterus. Mol Carcinog 2003;38:78-84
17. Miyagawa S, Katsu Y, Watanabe H, Iguchi T. Estrogen-independent activation of erBs signaling and estrogen receptor a in the mouse vagina exposed neonatally to diethylstilbestrol. Oncogene 2004;23:340-349
18. Nagai A, Ikeda Y, Aso T, Eto K, Ikeda MA. Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation. J Med Dent Sci 2003;50:35-40
19. Newbold RR, Banks P, Jefferson WN. Adverse effects of model environmental estrogen diethylstilbestrol (DES) are transmitted to subsequent generations. Endocrinology 2006; In press
20. Cook J, Davis BJ, Cai S, Barrett JC, Conti CJ, Walker CL. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci USA 2005;102:8644-8649
21. Baird DD, Newbold R. Prenatal diethylstilbestrol exposure is associated with uterine leiomyoma development. Reprod Toxicol 2005;20:81-84
22. Birnbaum LS, Fenton SE. Cancer and developmental exposures to endocrine disrupters. Environ Health Perspect 2003;111:389-394
23. Hunt PA, Koehler KE, Susiarjo M, et al. Bisphenol A exposure causes meiotic aneuploidy in the female mouse. Curr Biol 2003;13:546-553
24. Markey CM, Luque EH, Munoz de Toro M, Sonnenschein C, Soto SM. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001;65:1215-1223
25. Munoz-de-Toro M, Markey CM, Wadia P, et al. Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 2005;146:41 38-4147
26. Brown PK, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 1998;19:1623-1629
27. Fenton SE, Hamm JT, Birnbaum LS, Youngblood GI. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD). Toxicol Sci 2002;67:63-74
28. Rayner JL, Enoch RR, Fenton SE. Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci 2005;4:255-266
29. Alworth LC, Howdeshell KL, Ruhlen RL, Day JK, Lubahn DB, Huang THM. Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low verses high doses. Toxicol Appl Pharmacol 2002;183:10-22
30. Jefferson WN, Padilla-Banb E, Couse JF, Korach KS, Newbold RR. Neonatal genistein exposure induces estrogen receptor mediated alterations in gene expression in the developing mouse uterus: differential effects of low versus high doses. Mol Endocrinol 2005; In press
31. Hughes CL, Liu G, Beall S, Foster WG, Davis V. Effects of genistein or soy milk during late gestation and lactation on adult uterine organization in the rat. Exp Biol Med 2004; 229:108-117
32. Kouki T, Kishitake M, Okamoto M, Talebe M, Yamanouchiu I. Effects of neonatal treatment with phytoestrogens, genestein and daidzein on sex difference in female rat brain function: estrous cycle and lordosis. Horm Behav 2003;44:140-145
33. Hilakivi-Clarke L, Cho E, Onokafe I, Raygada M, Clark R. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 1999;6:1089-1095
34. Newbold RR, Banks EP, Bullock B, Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein, Cancer Res 2001;61:4325-4328
35. Jefferson WN, Couse JF, Padilla-Banb E, Korach KS, Newbold R. Neonatal exposure to genistein induces estrogen receptor (ERa) expression and multioocyte follicles in the maturing mouse ovary: evidence for ERb-mediated and nonestrogenic actions. Biol Reprod 2002;67:1285-1296
36. Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene 2001;278:25-31
37. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res Part A Clin Mol Technology 2005;73:478-480
38. Doerge DR, Twaddle NC, Banb EP, Jefferson WN, Newbold RR. Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice. Cancer Lett 2002;184:21-27
39. Goldman LR, Newbold R, Swan SH. Exposure to soy-based formula in infancy. JAMA 2001;286:2402-2403
40. Todaka E, Sakura K, Fukata H, et al. Fetal exposures to phytoestrogens-the difference in phytoestrogen statue between mother and fetus. Environ Res 2004;11:1-9
41. Abbott DA, Dumesic DA, Eisner JR, Kemnitz RJ, Goy RW. The Prenatally androgenized female rhesus monkey as a model for polycystic ovarian syndrome. In: Assiz R, Nestler JE, Dewailly D, eds. Androgen Excess Disorders in Women, Philadelphia; Lippincott-Raven; 1997:369-382
42. Eisner JR, Barnett MA, Dumesic DA, Abbott DA. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess, Fertil Steril 2002;77:167-172
43. Padmanabhan V, Evans E, Taylor JA, Robinson JE. Prenatal exposure to androgens leads to the development of cystic ovaries in the sheep. Biol Reprod 1998;56(suppl):194-199
44. Abbott DH, Dumesic DA, Franks S, Developmental origins of polycystic ovary syndrome: a hypothesis. J Endocrinol 2002;174:1-5
45. Takeuchi T, Tsutsynu O, Ikezuki Y, Takai Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004;51;165-169
46. Lin TM, Rasmussen NT, Moore RW, Albrecht RM, Peterson RE. Region-specific inhibition of prostatic epithelial bud formation in the urogenital sinus of C57B6 mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-P-dioxin. Toxicol Sci 2003;76:171-181
47. Timms BG, Peterson RE, Vom Saal FS. 2,3,7,8-Tetrachlorodibenzo-P-dioxin interacts with endogenous estradiol to disrupt prostate gland morphogenesis in male rat fetuses, Toxicol Sci 2002;67:264-274
48. Prins GS, Birch L, Habermann H, et al. Influence of neonatal estrogens on rat prostate developmental. Reprod Fertil Dev 2001;13:241-252
49. Pu Y, Huang L, Prins GS, Sonic hedgehog-patched gli signaling in the developing rat prostate gland: lobe-specific suppression by neonatal estrogens reduces ductal growth and branching. Dev Biol 2004;273:257-275
50. Welshons WV, Nagel SC, Thayer A, Judy BM, Vom Saal FS. Low dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoychlor and other xenoestrogens increases adult prostate size in mice. Toxicol Ind Health 1999;15:12-25
51. Ramos JG, Varayoud J, Sonnenschein C, Soto AM, Munoz de Toro MM, Luque EH. Prenatal exposure to low doses of bisphenol A alters the periductal stroma and glandular cell function in the rat ventral prostate. Biol Reprod 2001;65:1271-1277
52. Timms BG, Howdeshell KL, Barton L, Bradley S, Vom Saal FS. Estrogenic chemicals in plastic and oral contraceptives disrupt the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 2005;102:7014-7019
53. Vom Saal FS, Timms BG, Montano MM, et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 1997;94:2056-2061
54. Woodham C, Birch L, Prins GS, Neonatal estrogen down-regulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway. Endocrinology 2003; 144;4841-4850
55. Lund TD, Munson DJ, Adlercreutz H, Handa RJ, Lephart ED. Androgen receptor expression in the rat prostate is down regulated by dietary phytoestrogens. Reprod Biol Endocrinol 2004;16:5-11
56. Karri S, Johnson H, Hendry WJ III, Williams SC, Kahn SA. Neonatal exposures to diethylstilbestrol leads to impaired action of androgens in adult male hamsters. Reprod Toxicol 2005; In press
57. Kelce WR, Gray LE, Wilson EM. Antiandrogens as environmental endocrine disruptors. Reprod Fertil Dev 1998;10:105-111
58. Gray LE, Ostby J, Monosson E, Kelce WR. Environmental antiandrogens: low doses of the fungicide vindozolin alter sex differentiation of the male rat. Toxicol Ind Health 1999;15:48-64
59. Anway MD, Cupp AS, Uzumcu M, Skinner M. Epigenetic transgenerational actions of endocrine disrupters on male fertility. Science 2005;308:1466-1469
60. Novik KL, Nimmrich I, Gene B, et al. Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol 2002;4:111-128
61. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428
62. Van Driel R, Fransz PF, Verschure PJ. The eukaryotic genome: a system regulated at different hierarchical levels. J Cell Sci 2003;116:4067-4075
63. Reik W, Santos F, Dean W. Mammalian epigenomics: reprogramming the genome for development and therapy. Theriogenology 2003;59:21-32
64. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. Bioessays 2003;25:577-588
65. Kaneko-Ishino T, Kohda T, Ishino F. The regulation and biological significance of genomic imprinting. J Biochem (Tokyo) 2003;133:699-711